Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Diarrhea 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Octreotide 4Irinotecan 4Leucovorin 3Fluorouracil 3maltodextrin 1isatuximab 1bile acid binding proteins 1Standard of Care 1Radiation 1Probiotics 1PHY 906 1Oxaliplatin 1Loperamide 1Fecal Microbiota Transplantation 1Endoscopy 1Drugs, Investigational 1Control Groups 1Celecoxib 1Calcium Aluminosilicate 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diarrhea × Calcium Aluminosilicate × Gastrointestinal × Clear all
NCT00748215 2020-12-02

Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan

M.D. Anderson Cancer Center

Phase 2 Completed
100 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms, Diarrhea, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡